Catalyst Pharmaceuticals, Inc. EPS (Earnings per Share) 2002–2025
Catalyst Pharmaceuticals, Inc. reported $1.68 of earnings per share for fiscal 2025. That was 28.2% higher than fiscal 2024. Compared with fiscal 2020, the change was +136.6%.
| Fiscal year | EPS (Earnings per Share) | Change (YoY) |
|---|---|---|
| FY 2025 | $1.68 | +28.2% |
| FY 2024 | $1.31 | +107.9% |
| FY 2023 | $0.63 | -16.0% |
| FY 2022 | $0.75 | +102.7% |
| FY 2021 | $0.37 | -47.9% |
| FY 2020 | $0.71 | +136.7% |
| FY 2019 | $0.30 | +190.9% |
| FY 2018 | $-0.33 | — |
| FY 2017 | $0.00 | — |
| FY 2016 | $0.00 | — |
| FY 2015 | $0.00 | — |
| FY 2014 | $0.00 | — |
| FY 2013 | $0.00 | — |
| FY 2012 | $0.00 | — |
| FY 2011 | $0.00 | — |
| FY 2010 | $0.00 | — |
| FY 2009 | $0.00 | — |
| FY 2008 | $0.00 | — |
| FY 2007 | $0.00 | — |
| FY 2006 | $0.00 | — |
| FY 2005 | $0.00 | — |
| FY 2004 | $0.00 | — |
| FY 2003 | $0.00 | — |
| FY 2002 | $0.00 | — |
Source: Catalyst Pharmaceuticals, Inc. SEC filings — income statement (10-K), split-adjusted. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CPRX 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Catalyst Pharmaceuticals, Inc. reported $1.68 of earnings per share for fiscal 2025. That was 28.2% higher than fiscal 2024. Compared with fiscal 2020, the change was +136.6%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Catalyst Pharmaceuticals, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCatalyst Pharmaceuticals, Inc. — frequently asked questions
What is Catalyst Pharmaceuticals, Inc.'s earnings per share?
Catalyst Pharmaceuticals, Inc. (CPRX) reported earnings per share of $1.68 for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Catalyst Pharmaceuticals, Inc.'s official SEC filings (income statement (10-K), split-adjusted), refreshed nightly. Not investment advice.